Search results
Results from the WOW.Com Content Network
Linaclotide, (sold under the brand name Linzess in the US and Mexico, and as Constella elsewhere) [6] is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.
Lubiprostone, sold under the brand name Amitiza among others, is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company.
In determining bioequivalence between two products such as a commercially available Branded product and a potential to-be-marketed Generic product, pharmacokinetic studies are conducted whereby each of the preparations are administered in a cross-over study (sometimes parallel study, when a cross-over study is not feasible) to volunteer subjects, generally healthy individuals but occasionally ...
About the AMITIZA Development Program in Japan. Under the direction of Sucampo AG (SAG), a wholly owned subsidiary of SPI which holds all of SPI's patents and intellectual property, Sucampo Pharma ...
Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update Second quarter LINZESS ® (linaclotide) net product sales of $28.8 million, as reported by Forest Laboratories, Inc. CAMBRIDGE ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
The window between now and the conventions is the last chance for Biden or Trump to be tossed out without triggering other complications.